Theramex pioneers new treatment for post-menopausal women
September 24, 2021Medical Communications
Theramex has recently launched the first and only body-identical hormone therapy treatment (HRT) for post-menopausal women, in the form of …
Eurazeo set to become leading investor in Kurma Partners
September 24, 2021Medical Communications
Eurazeo has announced its intention to raise its stake in Kurma Partners, a French venture capital firm specialising in biotechnology …
AstraZeneca and MSD’s Lynparza shows potential for prostate cancer patients
September 24, 2021Medical Communications
The PROpel Phase III trial has shown that Lynparza (olaparib) in combination with abiraterone demonstrated a significant improvement in radiographic …
AstraZeneca and VaxEquity to collaborate on saRNA platform
September 24, 2021Medical Communications
AstraZeneca and VaxEquity have announced a collaboration to progress VaxEquity’s platform technology through proof of concept to enable the development …
CGT Catapult and Quell Therapeutics enter manufacturing collaboration
September 24, 2021Medical Communications
CGT Catapult and Quell Therapeutics have announced a collaboration to facilitate an expanded manufacturing footprint focusing on the manufacturing capacity …
Pfizer COVID-19 vaccine to be given to older and at-risk Americans
September 23, 2021Business Services
The FDA have approved a booster dose of the Pfizer BioNTech COVID-19 vaccine for those aged 65 and above, as …
Allarity Therapeutics partners with Lonza to manufacture Dovitinib
September 23, 2021Business Services
Allarity Therapeutics, a clinical-stage precision medicine company, has announced its collaboration with biopharma partner Lonza to manufacture dovitinib. Dovitinib targets …
Italy triples COVID vaccine donation pledge
September 23, 2021Italy has announced plans to donate 45 million doses of COVID-19 vaccines to other countries by the end of the …
Valneva expand COVID vaccine trials amid EC contract bid
September 23, 2021Valneva has announced the expansion of trials for its COVID-19 vaccine candidate, VLA2001, as it remains in talks with the …
Children in India to receive COVID-19 vaccine from October
September 22, 2021Research and Development
All Indian children aged 12 or older will become eligible for their COVID-19 vaccinations from next month, in the …
Dr. Christian Schetter hired as Chief Scientific Officer at Rentschler Biopharma
September 22, 2021Research and Development
Rentschler Biopharma has announced the appointment of Dr. Christian Schetter as their new CSO. In this position, Schetter will be …
HCA Healthcare to become one of MPT’s top tenants
September 22, 2021Research and Development
Medical Properties Trust (MPT) and HCA Healthcare have agreed to a 15-year master lease for hospitals representing $1.2 billion of …
CHMP recommends GSK’s Nucala (mepolizumab) for three eosinophil-driven diseases
September 22, 2021Research and Development
GlaxoSmithKline (GSK) has announced that the Committee for Medicinal Products for Human Use (CHMP) has issued positive feedback on …
Novartis champion advanced breast cancer survival data at ESMO 2021
September 22, 2021Research and Development
Novartis has presented captivating new data in advanced breast cancer, which championed the longest ever reported median overall survival, as …
University of Edinburgh partners with Cancer Research UK to build startup companies
September 22, 2021Research and Development
The University of Edinburgh’s Venture Builder Incubator, a business support programme, has partnered with Cancer Research UK to help build …
Government report finds serious overprescription issues in England
September 22, 2021Medical Communications, Research and Development
A government report has found serious overprescription issues in England, with 10% of items dispensed in primary care being overprescribed, …
J&J: Second COVID shot boosts effectiveness by 94%
September 22, 2021Medical Communications, Research and Development
Johnson & Johnson have released data showing that a second dose of their one shot COVID-19 vaccine boosts protection from …
FDA: Accelerated approval for Genmab and Seagen’s TIVDAK
September 21, 2021Manufacturing and Production, Research and Development
The FDA has granted accelerated approval for Genmab and Seagen’s TIVDAK (tisotumab vedotin-tftv), the first and only approved antibody-drug conjugate …
AstraZeneca to invest $340 million on Irish site
September 21, 2021Manufacturing and Production
AstraZeneca has announced on Tuesday a $340 million plan to establish an active pharmaceutical ingredient (API) manufacturing facility for small …
Vectura removed from DDL Conference amid PMI deal
September 21, 2021Manufacturing and Production DDL, inhalers, pmi, vectura
Inhaler and medical device maker Vectura has been removed from pharma conferences Formulation and Delivery UK and Drug Delivery to …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
